Who owns Exelixis?

Key details on Exelixis (Ticker: EXEL)

Who owns Exelixis?

Is EXEL a good stock to own? Find out who bought Exelixis, who sold Exelixis (EXEL) stock, and who holds a large position in Exelixis.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 22.57M $138.32M Dec. 31, 2013
T. Rowe Price Associates 19.30M $65.41M June 30, 2014
Meditor 19.07M $31.47M Sept. 30, 2014
FMR 17.14M $26.22M Sept. 30, 2014
Wellington Management Company 16.24M $55.06M June 30, 2014
STATE STREET CORPORATION 11.49M $17.59M Sept. 30, 2014
Vanguard 10.71M $16.39M Sept. 30, 2014
BNP PARIBAS ARBITRAGE, SNC 6.84M $616.42M March 31, 2014
BlackRock Fund Advisors 6.57M $10.05M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 6.32M $9.67M Sept. 30, 2014
Dr. Jeffrey R. Jay, M.D. 5.10M $7.80M Sept. 30, 2014
GOLDMAN SACHS 4.16M $14.72M March 31, 2014
SUSQUEHANNA INTERNATIONAL 3.34M $5.12M Sept. 30, 2014
OrbiMed Advisors 2.89M $10.22M March 31, 2014
Deutsche Bank Aktiengesellschaft 2.79M $8.93M June 30, 2014
BVF 2.50M $14.56M Sept. 30, 2013
Icahn Capital 2.36M $26.64M March 31, 2011
HealthCor Management 2.25M $7.96M March 31, 2014
NEA Management Company 2.21M $3.38M Sept. 30, 2014
Jennison Associates 2.21M $13.52M Dec. 31, 2013
NORTHERN TRUST 2.20M $3.37M Sept. 30, 2014
Millennium Management 2.05M $7.25M March 31, 2014
Baker Bros. Advisors 1.99M $11.00M June 30, 2012

Who sold Exelixis?

Fund Name Date Sold Number of Shares Sold Share Valuation
Deerfield Management Company Dec. 31, 2011 1.94M $9.19M